MedVital, a forward-thinking MedTech startup, has raised ₹8.4 crore in pre-seed funding to transform skin repair, wound healing, and aesthetic care in India. The funding round was spearheaded by Nihar Parikh’s 4point0 Health Ventures, with participation from notable operator-investors, including founders of Tata 1mg, NephroPlus, SafeExpress, and others.

India faces an increasing burden of hard-to-heal wounds, driven by factors like diabetes, obesity, trauma, and aging. Simultaneously, there’s a rising demand for non-invasive aesthetic treatments. MedVital addresses both these gaps with a unified, innovative approach.

The company is building India’s first integrated platform dedicated to advanced wound care and aesthetic solutions. Its flagship product, NoWound, is a compact, digitally enabled Negative Pressure Wound Therapy (NPWT) device designed for use in hospitals, clinics, and homes—especially where resources are limited.

Co-founder and CEO Dr. Varun Gupta emphasized the need for innovation in skin restoration, stating that the company is committed to delivering clinically validated solutions that are affordable and accessible. MedVital aims to support specialists in preventing amputations, healing complex wounds, and offering confidence-boosting aesthetic care.

The new funds will help expand MedVital’s product range, strengthen its supply chain, and widen its distribution to include tertiary hospitals, rural centers, and home-care setups.

COO Tarun Bansal added that the vision is to establish India as a global leader in wound care. Investor Nihar Parikh highlighted MedVital’s potential to meet critical healthcare needs with accessible, science-backed solutions.